Home›Companies›Biotech & Pharma›Growth Curve Bio

Growth Curve Bio, LLC

Updated Oct 29, 2026·Latest SEC filing Jul 10, 2024·Suggest an edit

About Growth Curve Bio

Growth Curve Bio is a private company based in Durham, North Carolina, incorporated in 2023 in Delaware. It has reported $3,485,001 raised in one offering on Form D since July 2024. Its chief executive is Eric Sabo.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 27, 2024Jul 10, 2024$3,485,001fully sold1$3.4MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Growth Curve Bio's Form D filed Jul 10, 2024.

BS
Ben Schultz
Executive officer and director
ES
Eric Sabo
Chief Executive Officer and director

Sources

  1. SECGrowth Curve Bio, LLC filing history